|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
|
ZA9610687B
(en)
*
|
1995-12-22 |
1997-09-29 |
Smithkline Beecham Corp |
Novel synthesis.
|
|
US6046208A
(en)
*
|
1996-01-11 |
2000-04-04 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
TR199801361T2
(xx)
*
|
1996-01-11 |
1998-10-21 |
Smithkline Beecham Corporation |
Yeni ikameli imidazol bile�imleri.
|
|
AP9700912A0
(en)
|
1996-01-11 |
1997-01-31 |
Smithkline Beecham Corp |
Novel cycloalkyl substituted imidazoles
|
|
US6096739A
(en)
*
|
1996-03-25 |
2000-08-01 |
Smithkline Beecham Corporation |
Treatment for CNS injuries
|
|
JP2000507545A
(ja)
*
|
1996-03-25 |
2000-06-20 |
スミスクライン・ビーチャム・コーポレイション |
Ｃｎｓ損傷についての新規な治療
|
|
EP0956018A4
(en)
|
1996-08-21 |
2000-01-12 |
Smithkline Beecham Corp |
IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
|
|
US5929076A
(en)
*
|
1997-01-10 |
1999-07-27 |
Smithkline Beecham Corporation |
Cycloalkyl substituted imidazoles
|
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
|
CA2288787A1
(en)
|
1997-05-22 |
1998-11-26 |
G.D. Searle And Co. |
Pyrazole derivatives as p38 kinase inhibitors
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
JP2002504909A
(ja)
|
1997-06-13 |
2002-02-12 |
スミスクライン・ビーチャム・コーポレイション |
新規な置換ピラゾールおよびピラゾリン化合物
|
|
AU8154998A
(en)
|
1997-06-19 |
1999-01-04 |
Smithkline Beecham Corporation |
Novel aryloxy substituted pyrimidine imidazole compounds
|
|
US6489325B1
(en)
|
1998-07-01 |
2002-12-03 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
EP1019396A1
(en)
|
1997-07-02 |
2000-07-19 |
SmithKline Beecham Corporation |
Novel cycloalkyl substituted imidazoles
|
|
US6562832B1
(en)
|
1997-07-02 |
2003-05-13 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
US7301021B2
(en)
|
1997-07-02 |
2007-11-27 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
TW517055B
(en)
|
1997-07-02 |
2003-01-11 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds
|
|
WO1999017776A1
(en)
|
1997-10-08 |
1999-04-15 |
Smithkline Beecham Corporation |
Novel cycloalkenyl substituted compounds
|
|
JP2001526230A
(ja)
|
1997-12-19 |
2001-12-18 |
スミスクライン・ビーチャム・コーポレイション |
ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
|
|
US6096899A
(en)
*
|
1998-04-14 |
2000-08-01 |
The Regents Of The University Of Michigan |
Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom
|
|
GB9809869D0
(en)
*
|
1998-05-09 |
1998-07-08 |
Medical Res Council |
Inhibition of protein kinases
|
|
CN1548436A
(zh)
|
1998-05-22 |
2004-11-24 |
ʷ��˿�������ȳ�ķ����˾ |
新的2-烷基取代咪唑化合物
|
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
WO2000010563A1
(en)
|
1998-08-20 |
2000-03-02 |
Smithkline Beecham Corporation |
Novel substituted triazole compounds
|
|
ATE258055T1
(de)
|
1998-11-04 |
2004-02-15 |
Smithkline Beecham Corp |
Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
|
|
US6239279B1
(en)
|
1998-12-16 |
2001-05-29 |
Smithkline Beecham Corporation |
Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
EP1223924A4
(en)
*
|
1999-09-17 |
2004-07-14 |
Smithkline Beecham Corp |
USE OF CSAIDS AGAINST RHINOVIRUS INFECTION
|
|
EP1233950B1
(en)
|
1999-11-23 |
2005-10-05 |
Smithkline Beecham Corporation |
3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
|
|
AU1783201A
(en)
|
1999-11-23 |
2001-06-04 |
Smithkline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
|
|
US6759410B1
(en)
|
1999-11-23 |
2004-07-06 |
Smithline Beecham Corporation |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
|
|
PT1175214E
(pt)
|
1999-12-08 |
2005-04-29 |
Pharmacia Corp |
Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
|
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
|
US6673818B2
(en)
|
2001-04-20 |
2004-01-06 |
Pharmacia Corporation |
Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
|
|
US7473695B2
(en)
*
|
2001-10-22 |
2009-01-06 |
Mitsubishi Tanabe Pharma Corporation |
4-imidazolin-2-one compounds
|
|
JP2005538066A
(ja)
|
2002-07-09 |
2005-12-15 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
新規な抗コリン作用薬及びｐ３８キナーゼ阻害剤を用いた新規な医薬組成物
|
|
US20050004098A1
(en)
*
|
2003-03-20 |
2005-01-06 |
Britten Nancy Jean |
Dispersible formulation of an anti-inflammatory agent
|
|
US20040214753A1
(en)
*
|
2003-03-20 |
2004-10-28 |
Britten Nancy Jean |
Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
|
|
DK1608407T3
(da)
*
|
2003-03-20 |
2006-12-04 |
Pharmacia Corp |
Dispergébar formulering af et antiinflammatorisk middel
|
|
US20050009931A1
(en)
*
|
2003-03-20 |
2005-01-13 |
Britten Nancy Jean |
Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
|
|
US7105467B2
(en)
*
|
2003-07-08 |
2006-09-12 |
Pharmacore, Inc. |
Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
|
|
US7105707B2
(en)
*
|
2003-12-17 |
2006-09-12 |
Pharmacore, Inc. |
Process for preparing alkynyl-substituted aromatic and heterocyclic compounds
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
WO2006062069A1
(ja)
*
|
2004-12-06 |
2006-06-15 |
Santen Pharmaceutical Co., Ltd. |
ｐ３８ＭＡＰキナーゼ阻害剤を有効成分とする掻痒治療剤
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
JP2007145819A
(ja)
*
|
2005-10-28 |
2007-06-14 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
WO2007056016A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Kemia, Inc. |
Bisamide cytokine inhibitors
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
|
EP3553169B1
(en)
|
2011-12-28 |
2021-11-03 |
Kyoto Prefectural Public University Corporation |
Normalization of culture of corneal endothelial cells
|
|
JP6730701B2
(ja)
|
2013-11-14 |
2020-07-29 |
学校法人同志社 |
細胞増殖促進または細胞障害抑制による角膜内皮治療薬
|
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
|
RS63581B1
(sr)
|
2017-10-05 |
2022-10-31 |
Fulcrum Therapeutics Inc |
Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju lečenja fshd
|
|
WO2022195579A1
(en)
|
2021-03-15 |
2022-09-22 |
Saul Yedgar |
Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases
|